Please assess the completion status of the following clinical trial:

Trial Title: Mitochondrial Function in Patients With Severe Liver Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Severe liver disease defined as known liver disease plus at least one of the following: serum albumin less than 3.0 g/dL or INR more than 2.0.~Exclusion Criteria:~* Portal systemic encephalopathy~* Pregnancy or breastfeeding.~* Anemia (hematocrit \< 32%)~* Significant weight loss or use of diet pills within previous 6 months.~* Cannot give informed consent, understand the protocol, or tolerate any aspect of the protocol.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Orally administered Labeled Glycerol (Type: EXPERIMENTAL): Patients will receive an oral mixture of \[U-13C3\]glycerol (25 mg/kg) plus unlabeled glycerol (25 mg/kg). The total dose of glycerol will be 50 mg/kg in 100 milliliters of water.

Based on this trial design, predict the completion outcome and termination type (if applicable).